Kronox Lab Sciences Intrinsic Value
Kronox Lab Sciences intrinsic value. Kronox Lab Sciences (KRONOX) median intrinsic value is ₹82.14 from 10 valuation models (range ₹41–₹125), vs current price ₹205.36 — -60.0% downside (Trading Above Calculated Value), margin of safety -100.0%. Read KRONOX dividend yield for the complete payout history and dividend yield track record.
KRONOX Valuation Methods Summary — DCF, Graham Number & P/E
Kronox Lab Sciences intrinsic value across 10 models vs current price ₹205.36 — upside/downside and value range per method. Compare with KRONOX fair value to assess whether the stock is under or overvalued.
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹93.60 | ₹74.88 - ₹112.32 | -54.4% | EPS: ₹7.80, Sector P/E: 12x |
| Book Value Method | asset | ₹41.07 | ₹36.96 - ₹45.18 | -80.0% | Book Value/Share: ₹31.35, P/B: 1.0x |
| Revenue Multiple Method | revenue | ₹61.61 | ₹55.45 - ₹67.77 | -70.0% | Revenue/Share: ₹30.00, P/S: 0.8x |
| EBITDA Multiple Method | earnings | ₹82.14 | ₹73.93 - ₹90.35 | -60.0% | EBITDA: ₹41.00Cr, EV/EBITDA: 6x |
| Simple DCF (5Y) | dcf | ₹88.11 | ₹70.49 - ₹105.73 | -57.1% | CF Growth: 15.0%, Discount: 15% |
| PEG Ratio Method | growth | ₹100.59 | ₹90.53 - ₹110.65 | -51.0% | EPS Growth: 16.1%, Fair P/E: 12.9x |
| Growth Adjusted P/E | growth | ₹63.39 | ₹57.05 - ₹69.73 | -69.1% | Revenue Growth: 3.2%, Adj P/E: 8.1x |
| ROE Based Valuation | profitability | ₹125.41 | ₹112.87 - ₹137.95 | -38.9% | ROE: 25.0%, P/E Multiple: 16x |
| Graham Defensive Method | conservative | ₹62.70 | ₹56.43 - ₹68.97 | -69.5% | EPS: ₹7.80, BVPS: ₹31.35 |
| Dividend Yield Method | dividend | ₹61.61 | ₹55.45 - ₹67.77 | -70.0% | DPS: ₹0.50, Target Yield: 3.5% |
KRONOX Intrinsic Value vs Market Price — All Valuation Models
Kronox Lab Sciences fair value range ₹41–₹125 vs current market price ₹205.36 across 10 valuation models. For current market price and key ratios, visit Kronox Lab Sciences screener.
KRONOX Intrinsic Value Analysis — Undervalued or Overvalued?
Kronox Lab Sciences median intrinsic value ₹82.14, current price ₹205.36 — Trading Above Calculated Value by 60.0%, margin of safety -100.0%.
What is the intrinsic value of KRONOX?
Based on our comprehensive analysis using 10 different valuation methods, the estimated intrinsic value of Kronox Lab Sciences (KRONOX) is ₹82.14 (median value). With the current market price of ₹205.36, this represents a -60.0% variance from our estimated fair value.
The valuation range spans from ₹41.07 to ₹125.41, indicating ₹41.07 - ₹125.41.
Is KRONOX undervalued or overvalued?
Based on our multi-method analysis, Kronox Lab Sciences (KRONOX) appears to be trading above calculated value by approximately 60.0%.
KRONOX Financial Health — Key Ratios vs Industry Benchmarks
Kronox Lab Sciences financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 79.00 | Industry Standard: 2.0+ | Above 2.0 | Measures short-term liquidity capacity |
| Return on Equity | 25.0% | Industry Standard: 15%+ | Above 15% | Measures shareholder return efficiency |
| Operating Margin | 33.0% | Industry Standard: 20%+ | Above 20% | Indicates operational efficiency level |
| Asset Turnover Ratio | 0.87x | Industry Standard: 1.0x+ | Above 0.5x | Measures asset utilization efficiency |
KRONOX Cash Flow Quality — Operating & Free Cash Flow
Kronox Lab Sciences operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2026 | ₹24 Cr | ₹12 Cr | Positive Free Cash Flow | 7/10 |
| March 2025 | ₹31 Cr | ₹17 Cr | Positive Free Cash Flow | 8/10 |
| March 2024 | ₹17 Cr | ₹9 Cr | Positive Free Cash Flow | 7/10 |
| March 2023 | ₹20 Cr | ₹17 Cr | Positive Free Cash Flow | 8/10 |
| March 2022 | ₹9 Cr | ₹5 Cr | Positive Free Cash Flow | 8/10 |